2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide

C19H24N2O2 — CID 167926329

IUPAC2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide
SMILESCC(C)C1CCCC1NC(=O)Cc1coc(-c2ccccc2)n1
InChIInChI=1S/C19H24N2O2/c1-13(2)16-9-6-10-17(16)21-18(22)11-15-12-23-19(20-15)14-7-4-3-5-8-14/h3-5,7-8,12-13,16-17H,6,9-11H2,1-2H3,(H,21,22)
InChIKeyBYASMZPNDCKMER-UHFFFAOYSA-N
MW312.41 g/mol
LogP3.83
Rot. Bonds5

About 2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide

2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide (PubChem CID 167926329) has the molecular formula C19H24N2O2 and a molecular weight of 312.41 g/mol. Its IUPAC name is 2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide.

Molecular Properties

Compound Name2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide
PubChem CID167926329
Molecular FormulaC19H24N2O2
Molecular Weight312.41 g/mol
Exact Mass312.18
IUPAC Name2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide
SMILESCC(C)C1CCCC1NC(=O)Cc1coc(-c2ccccc2)n1
InChIInChI=1S/C19H24N2O2/c1-13(2)16-9-6-10-17(16)21-18(22)11-15-12-23-19(20-15)14-7-4-3-5-8-14/h3-5,7-8,12-13,16-17H,6,9-11H2,1-2H3,(H,21,22)
InChIKeyBYASMZPNDCKMER-UHFFFAOYSA-N
XLogP3.83
TPSA55.13 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds5
Heavy Atoms23
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500312.41
LogP ≤ 53.83
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Analyze 2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-methyl-N-[2-[[2-(2-phenyl-1,3-oxazol-4-yl)acetyl]amino]ethyl]propanamide
CID 39436445
N-(1-phenylethyl)-2-(2-phenyl-1,3-oxazol-4-yl)acetamide
CID 51261759
3-methyl-1-(2-phenyl-1,3-oxazol-4-yl)butan-2-one
CID 164836493
N-[(1S)-1-[(1R,2R,4R)-2-bicyclo[2.2.1]heptanyl]ethyl]-2-(2-phenyl-1,3-oxazol-4-yl)acetamide
CID 98375689
N-(5-methylhexan-2-yl)-2-(2-phenyl-1,3-oxazol-4-yl)acetamide
CID 42886686
(2R)-2-[[2-(2-phenyl-1,3-oxazol-4-yl)acetyl]amino]propanamide
CID 94483610
N-(1-benzylpiperidin-4-yl)-2-(2-phenyl-1,3-oxazol-4-yl)acetamide
CID 38548867
2-(2-phenyl-1,3-oxazol-4-yl)-N-(4-propan-2-ylphenyl)acetamide
CID 39427955
N-(2,3-dihydro-1H-inden-1-yl)-2-(2-phenyl-1,3-oxazol-4-yl)acetamide
CID 51273832
N-[2-(aminomethyl)cyclopentyl]-2-[2-(4-fluorophenyl)-1,3-oxazol-4-yl]acetamide
CID 119603433
N-[1-(2-methylphenyl)ethyl]-2-(2-phenyl-1,3-oxazol-4-yl)acetamide
CID 51262103
N-(2-methylpiperidin-3-yl)-2-[(2-phenyl-1,3-oxazol-4-yl)methylsulfanyl]acetamide;hydrochloride
CID 120574731

Frequently Asked Questions

What is the IUPAC name of 2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide?
The IUPAC name of 2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide (CID 167926329) is 2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide.
What is the SMILES notation for 2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide?
The canonical SMILES for 2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide is CC(C)C1CCCC1NC(=O)Cc1coc(-c2ccccc2)n1.
What is the InChIKey of 2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide?
The InChIKey is BYASMZPNDCKMER-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H24N2O2/c1-13(2)16-9-6-10-17(16)21-18(22)11-15-12-23-19(20-15)14-7-4-3-5-8-14/h3-5,7-8,12-13,16-17H,6,9-11H2,1-2H3,(H,21,22).
What are the key properties of 2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide?
2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide has a molecular weight of 312.41 g/mol, XLogP of 3.83, 5 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(2-phenyl-1,3-oxazol-4-yl)-N-(2-propan-2-ylcyclopentyl)acetamide is sourced from PubChem (CID 167926329), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).